Insider-Trading
Aktuelle Insider-Transaktionen (SEC Form 4) — Käufe und Verkäufe von Vorständen, Direktoren und Großaktionären.
| Ticker | Insider | Funktion | Datum | Transaktion | Kurs ($) | Stück | Wert ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| INCY | Cagnoni Pablo J | President, Global Head of R&D | 15.09.2026 | Verkauf | 120,49 | 13.985 | 1.685.053 | Form 4 |
| INCY | Cagnoni Pablo J | President, Global Head of R&D | 15.09.2026 | Verkauf | 120,50 | 9.233 | 1.112.577 | Form 4 |
| INCY | Cagnoni Pablo J | President, Global Head of R&D | 15.09.2026 | Optionsausübung | 71,93 | 9.233 | 664.130 | Form 4 |
| INCY | Cagnoni Pablo J | President, Global Head of R&D | 15.09.2026 | Optionsausübung | 64,25 | 6.477 | 416.147 | Form 4 |
| INCY | Cagnoni Pablo J | President, Global Head of R&D | 15.09.2026 | Optionsausübung | 61,18 | 4.551 | 278.430 | Form 4 |
| INCY | Cagnoni Pablo J | President, Global Head of R&D | 15.09.2026 | Optionsausübung | 61,76 | 2.957 | 182.624 | Form 4 |
| INCY | Basi Ramitpal K | EVP, Human Resources | 25.08.2026 | Steuer-Abgabe | 129,72 | 504 | 65.379 | Form 4 |
| INCY | Cagnoni Pablo J | President, Global Head of R&D | 19.08.2026 | Verkauf | 125,56 | 10.801 | 1.356.174 | Form 4 |
| INCY | Cagnoni Pablo J | President, Global Head of R&D | 12.08.2026 | Verkauf | 120,04 | 10.803 | 1.296.792 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 05.08.2026 | Verkauf | 123,99 | 2.207 | 273.646 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 05.08.2026 | Optionsausübung | 106,47 | 2.207 | 234.979 | Form 4 |
| INCY | Cagnoni Pablo J | President, Global Head of R&D | 05.08.2026 | Verkauf | 122,69 | 10.640 | 1.305.422 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 03.08.2026 | Verkauf | 120,43 | 6.055 | 729.204 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 03.08.2026 | Optionsausübung | 105,43 | 6.055 | 638.379 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 31.07.2026 | Verkauf | 119,41 | 2.293 | 273.807 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 31.07.2026 | Verkauf | 121,69 | 326 | 39.671 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 31.07.2026 | Verkauf | 122,19 | 85 | 10.386 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 31.07.2026 | Verkauf | 119,38 | 1.642 | 196.022 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 31.07.2026 | Verkauf | 119,51 | 1.643 | 196.355 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 31.07.2026 | Verkauf | 119,40 | 2.864 | 341.962 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 31.07.2026 | Verkauf | 119,39 | 4.695 | 560.536 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 31.07.2026 | Verkauf | 119,43 | 6.171 | 737.003 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 31.07.2026 | Verkauf | 119,47 | 2.187 | 261.281 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 31.07.2026 | Verkauf | 119,42 | 5.332 | 636.747 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 31.07.2026 | Verkauf | 119,46 | 14.661 | 1.751.403 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 31.07.2026 | Optionsausübung | 105,43 | 326 | 34.370 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 31.07.2026 | Optionsausübung | 106,47 | 85 | 9.050 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 31.07.2026 | Optionsausübung | 90,56 | 2.293 | 207.654 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 31.07.2026 | Optionsausübung | 85,01 | 1.642 | 139.586 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 31.07.2026 | Optionsausübung | 83,20 | 3.023 | 251.514 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 31.07.2026 | Optionsausübung | 80,50 | 1.643 | 132.262 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 31.07.2026 | Optionsausübung | 77,67 | 2.864 | 222.447 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 31.07.2026 | Optionsausübung | 83,58 | 2.623 | 219.230 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 31.07.2026 | Optionsausübung | 72,27 | 9.459 | 683.602 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 31.07.2026 | Optionsausübung | 71,93 | 2.072 | 149.039 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 31.07.2026 | Optionsausübung | 68,62 | 3.148 | 216.016 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 31.07.2026 | Optionsausübung | 61,76 | 2.709 | 167.308 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 31.07.2026 | Optionsausübung | 64,25 | 2.284 | 146.747 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 31.07.2026 | Optionsausübung | 61,18 | 2.918 | 178.523 | Form 4 |
| INCY | Cagnoni Pablo J | President, Global Head of R&D | 31.07.2026 | Verkauf | 119,70 | 15.888 | 1.901.794 | Form 4 |
| INCY | Hoffman Richard A. | EVP & General Counsel | 16.07.2026 | Zuteilung | — | 7.395 | — | Form 4 |
| INCY | Gardner David H | EVP, Chief Strategy Officer | 16.07.2026 | Zuteilung | — | 7.395 | — | Form 4 |
| INCY | Basi Ramitpal K | EVP, Human Resources | 16.07.2026 | Zuteilung | — | 4.991 | — | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 16.07.2026 | Zuteilung | — | 5.916 | — | Form 4 |
| INCY | Issa Mohamed Khairie | EVP, Head of U.S. Commercial | 16.07.2026 | Zuteilung | — | 7.857 | — | Form 4 |
| INCY | Issa Mohamed Khairie | EVP, Head of U.S. Commercial | 16.07.2026 | Verkauf | 115,01 | 1.093 | 125.706 | Form 4 |
| INCY | Tray Thomas | Principal Accounting Officer | 16.07.2026 | Zuteilung | — | 2.834 | — | Form 4 |
| INCY | Stein Steven H | CMO & Head of Late-Stage Dev. | 16.07.2026 | Zuteilung | — | 9.798 | — | Form 4 |
| INCY | Stein Steven H | CMO & Head of Late-Stage Dev. | 16.07.2026 | Verkauf | 114,73 | 1.877 | 215.348 | Form 4 |
| INCY | Meury William | Chief Executive Officer | 16.07.2026 | Zuteilung | — | 26.807 | — | Form 4 |
| INCY | Cagnoni Pablo J | President, Global Head of R&D | 16.07.2026 | Zuteilung | — | 13.403 | — | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 15.07.2026 | Steuer-Abgabe | 115,09 | 1.512 | 174.016 | Form 4 |
| INCY | Issa Mohamed Khairie | EVP, Head of U.S. Commercial | 15.07.2026 | Steuer-Abgabe | 115,09 | 1.099 | 126.484 | Form 4 |
| INCY | Tray Thomas | Principal Accounting Officer | 15.07.2026 | Steuer-Abgabe | 115,09 | 1.098 | 126.369 | Form 4 |
| INCY | Stein Steven H | CMO & Head of Late-Stage Dev. | 15.07.2026 | Steuer-Abgabe | 115,09 | 3.088 | 355.398 | Form 4 |
| INCY | Stein Steven H | CMO & Head of Late-Stage Dev. | 15.07.2026 | Verkauf | 113,05 | 28.237 | 3.192.193 | Form 4 |
| INCY | Cagnoni Pablo J | President, Global Head of R&D | 15.07.2026 | Steuer-Abgabe | 115,09 | 4.950 | 569.696 | Form 4 |
| INCY | Mayes Patrick A | EVP & Chief Scientific Officer | 14.07.2026 | Steuer-Abgabe | 114,88 | 437 | 50.203 | Form 4 |
| INCY | Tray Thomas | Principal Accounting Officer | 14.07.2026 | Steuer-Abgabe | 114,88 | 692 | 79.497 | Form 4 |
| INCY | Stein Steven H | CMO & Head of Late-Stage Dev. | 14.07.2026 | Steuer-Abgabe | 114,88 | 21.830 | 2.507.830 | Form 4 |
Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).